09 May 2023

Project aims to deliver ‘new digital health workforce’

A new model will engage GPs, nurses and allied health via virtual care for chronic disease patients to help ease pressures off the hospital system.

09 May 2023

Budget reveals $5.7 billion general practice investment

Funding will go towards the creation of a new level E consultation item, rebate indexation, telehealth, the bulk billing incentive, and multidisciplinary care.

09 May 2023

Why health data hacks keep happening

A cancer centre is Australia’s latest cyber attack victim, with a criminal gang hoping to extort more than $100,000.

09 May 2023

TGA publishes updated guidelines for sunscreens

The TGA has updated the Australian Regulatory Guidelines for Sunscreens (ARGS) to align with the data requirements for all ingredients proposed to be included in the Therapeutic Goods (Permissible Ingredients) Determination (‘the Permissible Ingredients Determination’).

08 May 2023

GP considerations when prescribing medicinal cannabis

SPONSORED: Medicinal cannabis prescription rates are increasing – what does the latest research say about its safety?

08 May 2023

Australian-first study reveals full scope of GP skin cancer care

Researchers hope the findings will help guide education, policy and interventions to optimise skin cancer prevention and management.

08 May 2023

GP sued for defamation by naturopath faces millions in legal fees

In his quest to debunk medical misinformation, Dr Adam Smith has found himself embroiled in a legal saga that has now stretched for more than two years.

08 May 2023

ASTHMA AUSTRALIA’S 2023 TASMANIAN ASTHMA DISCOVERY SURVEY – TELL US YOUR STORY!

Asthma Australia wants to know more about what life is like for Tasmanians experiencing breathing problems and asthma.

08 May 2023

Publication of Notification Form for likely or actual breach of minimum stockholding requirements

Publication of Notification Form for likely or actual breach of minimum stockholding requirements

08 May 2023

Hydrocortisone shortage

The Therapeutic Goods Administration is aware of a shortage of all hydrocortisone tablet strengths due to manufacturing issues. We are working with the supplier Alphapharm Pty Ltd to manage the impact.